{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:16304"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:16304","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Understanding the regulators of adaptive tolerance in chronically stimulated CD4+ T-cells.","abstract":"Chronic T-cell receptor (TCR) stimulation is a central driver of CD4+ T-cell hyporesponsiveness. During prolonged stimulation, CD4+ T-cells either enter a state of tolerance, mimicking anergy, or differentiate into type-1 regulatory T-cells (Tr1), a distinct FoxP3- regulatory T-cell (Treg) subset crucial for maintaining immune tolerance via IL10 production. The specific regulators of adaptive tolerance, and how they differ from CD8+ T-cell exhaustion, remain unclear. Moreover, the signalling dynamics within Tr1-like cells and their environmental modulation are not well understood yet are of significant therapeutic interest. To study chronic-stimulation induced tolerance, Nur77-Tempo mice received escalation dose immunotherapy, allowing us to analyse NFAT-independent TCR signalling. Our study reveals that chronic stimulation-induced tolerance in CD4+ T-cells is associated with increased immune checkpoint (IC) expression and increased Tr1-like selection. These tolerised T-cells display intrinsic signalling defects in multiple T-cell signalling pathways which can be reversed by combined IC blockade (anti-PD-L1 and anti-Lag3) in-vivo. Importantly, Tr1-like cells remain responsive to chronic antigen exposure and exhibit heightened sensitivity to IC blockade. While the total and responsive Tr1-like cell populations increase following combination therapy, IL10 expression levels remain stable, indicating that ICs may regulate IL10 production within Tr1-like cells. We conclude that shared biological mechanisms underpin different forms of T-cell dysfunction, including tolerance and exhaustion. ICs are pivotal in enforcing tolerance, yet their function evolves following Tr1 differentiation, supporting the maintenance of a tolerogenic state. These findings suggest a need for further research to understand the impact of IC blockade on Tr1-like cells in various disease contexts, including cancer.","abstract_html":"Chronic T-cell receptor (TCR) stimulation is a central driver of CD4+ T-cell hyporesponsiveness. During prolonged stimulation, CD4+ T-cells either enter a state of tolerance, mimicking anergy, or differentiate into type-1 regulatory T-cells (Tr1), a distinct FoxP3- regulatory T-cell (Treg) subset crucial for maintaining immune tolerance via IL10 production. The specific regulators of adaptive tolerance, and how they differ from CD8+ T-cell exhaustion, remain unclear. Moreover, the signalling dynamics within Tr1-like cells and their environmental modulation are not well understood yet are of significant therapeutic interest. To study chronic-stimulation induced tolerance, Nur77-Tempo mice received escalation dose immunotherapy, allowing us to analyse NFAT-independent TCR signalling. Our study reveals that chronic stimulation-induced tolerance in CD4+ T-cells is associated with increased immune checkpoint (IC) expression and increased Tr1-like selection. These tolerised T-cells display intrinsic signalling defects in multiple T-cell signalling pathways which can be reversed by combined IC blockade (anti-PD-L1 and anti-Lag3) in-vivo. Importantly, Tr1-like cells remain responsive to chronic antigen exposure and exhibit heightened sensitivity to IC blockade. While the total and responsive Tr1-like cell populations increase following combination therapy, IL10 expression levels remain stable, indicating that ICs may regulate IL10 production within Tr1-like cells. We conclude that shared biological mechanisms underpin different forms of T-cell dysfunction, including tolerance and exhaustion. ICs are pivotal in enforcing tolerance, yet their function evolves following Tr1 differentiation, supporting the maintenance of a tolerogenic state. These findings suggest a need for further research to understand the impact of IC blockade on Tr1-like cells in various disease contexts, including cancer.","abstract_has_math":false,"creators":["Done, Reygn"],"institution":"University of Birmingham","degree_name":"m_sc","degree_level":"m_sc","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025-07","date_published":"2025-07","updated_at":"2026-11-19T09:33:12Z","subjects":["RC Internal medicine"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/16304/1/Done2025MScbyRes.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A16304","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Done, Reygn"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2025-07-14"]},{"key":"dc:date.issued","label":"Date","values":["2025-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medicine and Health","School of Infection, Inflammation and Immunology, Department of Immunology and Immunotherapy"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/16304/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["m_sc"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["m_sc"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RC Internal medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/16304/1/Done2025MScbyRes.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Chronic T-cell receptor (TCR) stimulation is a central driver of CD4+ T-cell hyporesponsiveness. During prolonged stimulation, CD4+ T-cells either enter a state of tolerance, mimicking anergy, or differentiate into type-1 regulatory T-cells (Tr1), a distinct FoxP3- regulatory T-cell (Treg) subset crucial for maintaining immune tolerance via IL10 production. The specific regulators of adaptive tolerance, and how they differ from CD8+ T-cell exhaustion, remain unclear. Moreover, the signalling dynamics within Tr1-like cells and their environmental modulation are not well understood yet are of significant therapeutic interest. To study chronic-stimulation induced tolerance, Nur77-Tempo mice received escalation dose immunotherapy, allowing us to analyse NFAT-independent TCR signalling. Our study reveals that chronic stimulation-induced tolerance in CD4+ T-cells is associated with increased immune checkpoint (IC) expression and increased Tr1-like selection. These tolerised T-cells display intrinsic signalling defects in multiple T-cell signalling pathways which can be reversed by combined IC blockade (anti-PD-L1 and anti-Lag3) in-vivo. Importantly, Tr1-like cells remain responsive to chronic antigen exposure and exhibit heightened sensitivity to IC blockade. While the total and responsive Tr1-like cell populations increase following combination therapy, IL10 expression levels remain stable, indicating that ICs may regulate IL10 production within Tr1-like cells. We conclude that shared biological mechanisms underpin different forms of T-cell dysfunction, including tolerance and exhaustion. ICs are pivotal in enforcing tolerance, yet their function evolves following Tr1 differentiation, supporting the maintenance of a tolerogenic state. These findings suggest a need for further research to understand the impact of IC blockade on Tr1-like cells in various disease contexts, including cancer."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Understanding the regulators of adaptive tolerance in chronically stimulated CD4+ T-cells."]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Done, Reygn"],"dc:date":["2025-07-14"],"dc:date.issued":["2025-07"],"dc:description.abstract":["Chronic T-cell receptor (TCR) stimulation is a central driver of CD4+ T-cell hyporesponsiveness. During prolonged stimulation, CD4+ T-cells either enter a state of tolerance, mimicking anergy, or differentiate into type-1 regulatory T-cells (Tr1), a distinct FoxP3- regulatory T-cell (Treg) subset crucial for maintaining immune tolerance via IL10 production. The specific regulators of adaptive tolerance, and how they differ from CD8+ T-cell exhaustion, remain unclear. Moreover, the signalling dynamics within Tr1-like cells and their environmental modulation are not well understood yet are of significant therapeutic interest. To study chronic-stimulation induced tolerance, Nur77-Tempo mice received escalation dose immunotherapy, allowing us to analyse NFAT-independent TCR signalling. Our study reveals that chronic stimulation-induced tolerance in CD4+ T-cells is associated with increased immune checkpoint (IC) expression and increased Tr1-like selection. These tolerised T-cells display intrinsic signalling defects in multiple T-cell signalling pathways which can be reversed by combined IC blockade (anti-PD-L1 and anti-Lag3) in-vivo. Importantly, Tr1-like cells remain responsive to chronic antigen exposure and exhibit heightened sensitivity to IC blockade. While the total and responsive Tr1-like cell populations increase following combination therapy, IL10 expression levels remain stable, indicating that ICs may regulate IL10 production within Tr1-like cells. We conclude that shared biological mechanisms underpin different forms of T-cell dysfunction, including tolerance and exhaustion. ICs are pivotal in enforcing tolerance, yet their function evolves following Tr1 differentiation, supporting the maintenance of a tolerogenic state. These findings suggest a need for further research to understand the impact of IC blockade on Tr1-like cells in various disease contexts, including cancer."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/16304/1/Done2025MScbyRes.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medicine and Health","School of Infection, Inflammation and Immunology, Department of Immunology and Immunotherapy"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/16304/"],"dc:subject":["RC Internal medicine"],"dcterms:accessrights":["public"],"dc:title":["Understanding the regulators of adaptive tolerance in chronically stimulated CD4+ T-cells."],"dc:type":["Thesis"],"dc:type.qualificationlevel":["m_sc"],"dc:type.qualificationname":["m_sc"]},"updated_at":"2026-11-19T09:33:12Z"}